Psychedelic treatments move closer to mainstream at FDA
Psychedelic drug treatments are gaining momentum at the federal level, prompting the Food and Drug Administration to solicit public input on the potential supervised therapeutic use of psychedelic drugs.
TL;DR
- The FDA is soliciting public input on the supervised therapeutic use of psychedelic drugs.
- Psychedelic drug treatments are gaining momentum at the federal level.
- This indicates increased consideration for psychedelic therapies within the federal government.